Chemical conversion of nicotinamide into type I positive allosteric modulator of α7 nAChRs

Add time:08/28/2019    Source:sciencedirect.com

Structural modifications of nicotinamide, a form of vitamin B3, gave rise to a series of compounds (8aa–8ce) that exhibit activities as type I positive allosteric modulators (PAMs) of human α7 nAChR expressed in Xenopus oocytes in two-electrode voltage clamp assay. The compound 8ai was a potent and efficacious PAM with an EC50 = 3.34 ± 1.13 μM and the maximum activation effect of α7 current over 1474 ± 246% in the presence of acetylcholine (100 μM). It is highly specific to α7 nAChR over other subtypes of nAChR and 5-HT3A receptors. The structure–activity relationship analysis identified a key skeleton of nicotinamide nucleus critical for biological activity. Taken together, the 8ai as a type I PAM of α7 nAChR may be beneficial for improvement of cognitive deficit.

We also recommend Trading Suppliers and Manufacturers of I 278 (cas 113739-44-9). Pls Click Website Link as below: cas 113739-44-9 suppliers

Prev:Gene expression profile after activation of RIG-I in 5'ppp-dsRNA challenged DF1
Next:Research paperStructure, spectra and electrical conductivity of copper(I) and silver(I) phosphino bridging mixed ligand complexes with coumarinyl Schiff base)